Cargando…
From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients
The management of hyperglycemia in patients admitted to hospital is mainly based on insulin therapy. However, the positive and rapid effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on cardiorenal outcomes raises the possibility that they might confer benefits to hospitalized patients....
Autores principales: | Koufakis, Theocharis, Mustafa, Omar G., Ajjan, Ramzi A., Garcia-Moll, Xavier, Zebekakis, Pantelis, Dimitriadis, George, Kotsa, Kalliopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9178534/ https://www.ncbi.nlm.nih.gov/pubmed/35678922 http://dx.doi.org/10.1007/s40265-022-01730-2 |
Ejemplares similares
-
Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
por: Koufakis, Theocharis, et al.
Publicado: (2021) -
The Relationship between Primary Hyperparathyroidism and Thrombotic Events: Report of Three Cases and a Review of Potential Mechanisms
por: Koufakis, Theocharis, et al.
Publicado: (2018) -
Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?
por: Koufakis, Theocharis, et al.
Publicado: (2022) -
Pharmacologic adjunctive to insulin therapies in type 1 diabetes: The journey has just begun
por: Karras, Spyridon N, et al.
Publicado: (2019) -
Looking deeper into the findings of DARE-19: Failure or an open door to future success?
por: Koufakis, Theocharis, et al.
Publicado: (2021)